UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$469M |
| 2 |
Fidelity National Information Services
FIS
|
+$352M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$337M |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$316M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.92B |
| 2 |
UBS Group
UBS
|
+$1.46B |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$547M |
| 4 |
Microsoft
MSFT
|
+$461M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.47% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 5.76% |
| 5 | Industrials | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVI
4426
DELISTED
Retail Value Inc. Common Shares
RVI
| $580K | ﹤0.01% |
170,824
+84,584
| +98% | +$286K |
|
|
DS
4427
DELISTED
Drive Shack Inc.
DS
| $578K | ﹤0.01% |
134,127
-16,878
| -11% | -$79.5K |
|
4428
PUT
Toronto Dominion Bank
TD
$200B
| $577K | ﹤0.01% |
9,900
-2,800
| -22% | -$159K |
|
4429
Virtus Investment Partners
VRTS
$1.1B
| $576K | ﹤0.01% |
5,205
+3,069
| +144% | +$330K |
|
|
CARO
4430
DELISTED
Carolina Financial Corp.
CARO
| $576K | ﹤0.01% |
16,210
+11,798
| +267% | +$411K |
|
4431
Tidewater
TDW
$4.12B
| $575K | ﹤0.01% |
38,067
+23,157
| +155% | +$436K |
|
4432
CALL
Adient
ADNT
$1.5B
| $574K | ﹤0.01% |
+25,000
| New | +$570K |
|
4433
VanEck Pharmaceutical ETF
PPH
$938M
| $573K | ﹤0.01% |
10,052
-1,767
| -15% | -$101K |
|
4434
The RMR Group
RMR
$332M
| $573K | ﹤0.01% |
12,605
+9,096
| +259% | +$428K |
|
4435
Scansource
SCSC
$1.12B
| $573K | ﹤0.01% |
18,772
+7,064
| +60% | +$220K |
|
|
CDK
4436
CALL
DELISTED
CDK Global, Inc.
CDK
| $572K | ﹤0.01% |
+11,900
| New | +$570K |
|
|
AVX
4437
DELISTED
AVX Corporation
AVX
| $572K | ﹤0.01% |
37,589
+28,192
| +300% | +$425K |
|
4438
National Beverage
FIZZ
$3.01B
| $570K | ﹤0.01% |
25,700
+3,744
| +17% | +$80.8K |
|
4439
SiriusPoint
SPNT
$2.68B
| $570K | ﹤0.01% |
57,086
-571,733
| -91% | -$5.74M |
|
4440
State Street SPDR S&P Global Dividend ETF
WDIV
$281M
| $569K | ﹤0.01% |
8,432
+246
| +3% | +$16.3K |
|
|
BBF
4441
DELISTED
BlackRock Municipal Income Investment Trust
BBF
| $568K | ﹤0.01% |
40,518
+16,098
| +66% | +$227K |
|
4442
WisdomTree Enhanced Commodity Strategy Fund
GCC
$274M
| $567K | ﹤0.01% |
32,312
-6,120
| -16% | -$107K |
|
|
MNP
4443
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
| $567K | ﹤0.01% |
37,040
+6,450
| +21% | +$98.2K |
|
|
NBO
4444
DELISTED
Neuberger Berman New York Municipal Fund Inc.
NBO
| $567K | ﹤0.01% |
45,315
-58,605
| -56% | -$728K |
|
4445
CALL
Thor Industries
THO
$4.14B
| $566K | ﹤0.01% |
+10,000
| New | +$525K |
|
4446
Pricesmart
PSMT
$5.46B
| $564K | ﹤0.01% |
7,931
-1,041
| -12% | -$63.1K |
|
|
CRHM
4447
DELISTED
CRH Medical Corporation
CRHM
| $564K | ﹤0.01% |
183,071
-1,977
| -1% | -$5.87K |
|
|
IPHS
4448
DELISTED
Innophos Holdings, Inc.
IPHS
| $564K | ﹤0.01% |
17,354
+10,421
| +150% | +$300K |
|
4449
BioXcel Therapeutics
BTAI
$27.8M
| $563K | ﹤0.01% |
4,994
+271
| +6% | +$42.7K |
|
4450
Dynagas LNG Partners
DLNG
$137M
| $563K | ﹤0.01% |
284,411
+7,215
| +3% | +$9.89K |
|
Similar funds
UBS Group's Q3 2019 Portfolio in Review
As of Q3 2019, UBS Group held 8,655 positions worth $260B, up 0.05% from $260B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2019 filing shows 737 new, 4,060 increased, 2,893 reduced and 594 closed positions. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M.
- UBS Group added most to iShares US Treasury Bond ETF in Q3 2019, an estimated $469M increase.
- UBS Group's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.92B.
- UBS Group fully exited OAKTREE CAPITAL GROUP, LLC in Q3 2019, selling an estimated $172M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q3 2019.
- UBS Group opened 737 new positions and closed 594 in Q3 2019.
- UBS Group's portfolio value rose 0.05% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.